XENON PHARMACEUTICALS INC. (XENE)

SEC filing

XENON PHARMACEUTICALS INC.

XENE · CIK 1582313

4 · Oct 1, 2026 · Chief Financial Officer Kelly Thomas Patrick bought 15K Common Shares at $37.32/unit ($559.7K)

Chief Financial Officer Kelly Thomas Patrick bought 15K Common Shares at $37.32/unit ($559.7K)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).